Mair Therapeutics focuses on developing innovative therapies that harness the power of the immune system to combat various diseases, particularly cancer. The company employs a proprietary platform that integrates advanced immunotherapy techniques, aiming to enhance the body’s natural ability to fight tumors. Their pipeline includes a range of product candidates designed to target specific pathways involved in immune response, thereby improving the efficacy and safety of treatments for patients.

In addition to their immunotherapy approach, Mair Therapeutics is committed to leveraging cutting-edge research in molecular biology and genetics to inform their drug development processes. This includes utilizing insights from the tumor microenvironment and immune cell interactions to create more personalized treatment options. By combining these scientific advancements with their therapeutic strategies, Mair Therapeutics aims to deliver transformative solutions that address unmet medical needs in oncology and beyond.

Netherlands

Mair Therapeutics is a preclinical-stage drug discovery company focused on the discovery and development of a small-molecule ion channel activator to treat Parkinson's disease.

Mair Therapeutics

Company Details